BTAI - BioXcel Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BTAI is currently covered by 6 analysts with an average price target of $60.24. This is a potential upside of $56.14 (1369.27%) from yesterday's end of day stock price of $4.1.

BioXcel Therapeutics's activity chart (see below) currently has 86 price targets and 91 ratings on display. The stock rating distribution of BTAI is 19.23% HOLD, 76.92% BUY and 3.85% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.54% with an average time for these price targets to be met of 289.8 days.

Highest price target for BTAI is $10, Lowest price target is $4, average price target is $11.5.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 19-Aug-2025. First documented stock forecast 02-Apr-2018.

Currently out of the existing stock ratings of BTAI, 5 are a HOLD (19.23%), 20 are a BUY (76.92%), 1 are a SELL (3.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$5.02 (100.80%)

$10

9 days ago
(19-Aug-2025)

6/21 (28.57%)

$5.08 (103.25%)

564

Sell

$4

$-0.98 (-19.68%)

$23

7 months 21 days ago
(07-Jan-2025)

4/4 (100%)

$-3.54 (-46.95%)

378

Buy

7 months 22 days ago
(06-Jan-2025)

9/11 (81.82%)

$-52.4 (-74.43%)

446

Hold

$16

$11.02 (221.29%)

$64

1 years 16 days ago
(12-Aug-2024)

7/10 (70%)

$5.48 (52.09%)

48

Hold

$16

$11.02 (221.29%)

$56

1 years 19 days ago
(09-Aug-2024)

1/4 (25%)

$4.3 (36.75%)

280

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTAI (BioXcel Therapeutics) average time for price targets to be met?

On average it took 289.8 days on average for the stock forecasts to be realized with a an average price target met ratio 63.54

Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?

Raghuram Selvaraju has 3 price targets and 18 ratings on BTAI

Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?

Do Kim with highest potential upside - $1659.02

Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?

Geoff Meacham with lowest potential downside - -$0.98

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?